Fibrino(geno)lytic properties of purified hementerin, a metalloproteinase from the leech Haementeria depressa

Thrombosis and Haemostasis

Volumn 80, Issue 1, 1998, Pages 155-160

  Chudzinski Tavassi, Ana Marisa ^a   Kelen, Eva Maria A ^a   De Paula Rosa, Ana Paula ^a   Loyau, Stephane ^b   Sampaio, Claudio A M ^c   Bon, Cassian ^d   Anglés Cano, Eduardo ^b,e  

^a INSTITUTO BUTANTAN   (Brazil)

^b BICÊTRE HOSPITAL   (France)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUT PASTEUR   (France)

^e Dept Environ Med Natl Inst Publ HIth   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; HEMENTERIN; METALLOPROTEINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; GEL FILTRATION; ION EXCHANGE CHROMATOGRAPHY; LEECH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN PURIFICATION;

EID: 0031927813     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615155     Document Type: Article

References (43)

1. Sabbatani L. Ferment anticoagulant de 1 "Ixodes ricinus". Arch Ital Biol 1899; 31: 37-53.
2. Haycraft JB. Über die Einwirkung eines Sekretes des officinellen Blutegels auf die Gerinnbarkeit des Blutes. Naunyn-Schmiedeberg's Arch Exp Path Pharmak 1884; 18: 209-17.
3. Markwardt F. Hirudin as an inhibitor of thrombin, in Methods in Enzymology. Perlmann GE, Lorand L, eds. New York: Academic Press 1470; 19: 924-32.
4. Bergmann C, Dodt J, Köhler S, Fink E, Gassen HG. Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis. Biol Chem Hoppe Seyler 1986; 367: 731-40.
5. Fortkamp E, Rieger M, Heisterberg-Moutses G, Schweitzer S, Sommer R. Cloning and expression in Escherichia coli of a synthetic DNA for hirudin, the blood coagulation inhibitor in the leech. DNA 1986; 5: 511-7.
6. Harvey RP, Degryse E, Stefani L, Schamber F, Cazenave JP, Courtney M, Tolstohev P, Lecocq JP. Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech Hirudo medicinalis. Proc Natl Acad Sci USA 1986; 83: 1084-8.
7. Zawilska K, Zozulinska M, Turowiecka Z, Blahut M, Drobnik L, Vinazzer H. The effect of a long-acting recombinant hinidin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits. Thromb Res 1993; 69: 315-20.
8. Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Haemost 1991; 66: 141-52.
9. Kelen EMA, Rosenfeld G. Fibrinogenolytic substance (Hementerin) of Brazilian blood-sucking leeches (Haementeria lutzi Pinto 1920). Haemostasis 1975; 4: 51-64.
10. Kelen EMA, Hruby VJ, Tomy SC, Pinheiro ME. Hementerin, a potent in vitro activator of the human fibrinolytic system. In: Progress in Fibrinolysis (Davidson JF, Bachmann F, Bouvier CA, Kruithof EKO, eds. Edinburgh: Churchill Livingstone 1983; 6: 95-8.
11. Budzynski AZ, Olexa SA, Sawyer RT. Composition of salivary gland extracts from the leech Haementeria ghilianii. Proc Soc Exp Biol Med USA 1981; 168: 259-65.
12. Malinconico SM, Katz JB, Budzynski AZ. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii. J Lab Clin Med 1984; 104: 842-54.
13. Swadesh JK, Huang IY, Budzynski AZ. Purification and characterization of hementin, a fibrinogenolytic protease from the leech Haementeria ghilianii. J Chromatography 1990; 502: 359-69.
14. Condra C, Nutt E, Petroski CJ, Simpson E, Friedman PA, Jacobs JW. Isolation and structural characterization of a potent inhibitor of coagulation factor Xa from the leech Haementeria ghilianii. Thromb Haemost 1989; 61: 437-41.
15. Tuszynski GP, Gasic TB, Gasic GJ. Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation. J Biol Chem 1987; 262: 9718-23.
16. Dunwiddie C, Thromberry NA, Bull HG, Sardana M, Friedman PA, Jacobs JW, Simpson E. Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site. J Biol Chem 1988; 264: 16694-9.
17. Seymour JL, Henzel WJ, Nevins B, Stults JT, Lazarus A. Decorsin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J Biol Chem 1990; 265: 10143-7.
18. Mazur P, Henzel WJ, Seymour JL, Lazarus RA. Ornatins: potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata. Eur J Biochem 1991; 202: 1073-82.
19. Kelen EMA. Substancia anticoagulante de sanguessuga brasileira (Gen. Haementeria de Filippi, 1849)-(Annelide-Hirudinea). Thesis, Instituto de Biociências (Depto de Fisiologia Geral), Universidade de São Paulo 1972.
20. Ringuelet RA. Sobre la identidad de Blennobdella depressa Em. Blanchard, 1849 y la existencia de Haementeria officinalis de Filippi, 1849 en Estados Unidos (Hirudinea, Glossiphoniiformes). Physis 1972; 31: 97-8.
21. Ringuelet RA. Hirudinea. In: Biota acuatica de Sudamérica Austral. Hulbert SH, ed. San Diego State University 1977; 122-9.
22. Kazal LA, Amsel S, Miller OP, Tocantins LM. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med USA 1963; 113: 989-94.
23. 308-Lys) does not affect the binding of t-PA and plasminogen to fibrin. Blood Coag Fibrinolysis 1993; 4: 679-87.
24. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-6.
25. Fleury V, Anglés-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 1991; 30: 7630-8.
26. Markwell MAK, Haa SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206-10.
27. Chudzinski-Tavassi AM. Proteínas anticoagulantes das glândulas salivares da sanguessuga Haementeria depressa. Ph.D. Thesis of Molecular Biology. Universidade Federal de São Paulo-Escola Paulista de Medicina; São Paulo 1993.
28. Denson KWE. Techniques. In: Human blood coagulation, haemostasis and thrombosis. Biggs R, ed. Oxford: Blackwell Scientific Publications 1976: 721-2.
29. Jespersen J, Astrup T. A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Haemostasis 1983; 13: 301-15.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
31. Gaussem P, Grailhe P, Anglés-Cano E. Sodium dodecyl sulfate-induced dissociation of complexes between tissue plasminogen activator and its specific inhibitor. J Biol Chem 1993; 268: 12150-5.
32. Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 1968; 244: 4406-12.
33. Morrissey JH. Silver stain for proteins in polyacrylamide gels, a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981; 117: 307-10.
34. Gaussem P, Anglés-Cano E. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate. Biochim Biophys Acta 1991; 1079: 321-9.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
36. Anglés-Cano E. A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-TPA) for high-fibrin-affinity tissue plasminogen activators. Anal Biochem 1986; 153: 201-10.
37. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
38. Koppert PW, Koopman J, Haverkate F, Nieuwenhuizen W. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising Bβ 54-118) in degradation products of fibrin and of fibrinogen. Blood 1986; 68: 437-41.
39. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ, Wyatt D, Bundesen PG. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-78.
40. Nieuwenhuizen W, Verheijen JH, Vermond A, Chang GTG. Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2. Biochim Biophys Acta 1983; 755: 531-3.
41. Kirschbaum NE, Budzynski AZ. A unique proteolytic fragment of human fibrinogen containing the A-alpha COOH-terminal domain of the native molecule. J Biol Chem 1990; 265: 13669-76.
42. Budzynski AZ. Interaction of hementin with fibrinogen and fibrin. Blood Coag Fibrinolysis 1991; 2: 149-52.
43. Marder VJ, Shulman NR. High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanisms of their anticoagulant activity. J Biol Chem 1969; 244: 2120-4.